Literature DB >> 23771846

Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease.

Petra Laššuthová1, Markéta Žaliová2, Ken Inoue3, Jana Haberlová4, Klára Sixtová5, Iva Sakmaryová4, Kateřina Paděrová4, Radim Mazanec6, Josef Zámečník7, Dana Šišková5, Jim Garbern8, Pavel Seeman4.   

Abstract

Pelizaeus-Merzbacher disease is a severe X-linked disorder of central myelination caused by mutations affecting the proteolipid protein gene. We describe 3 new PLP1 splicing mutations, their effect on splicing and associated phenotypes. Mutation c.453_453+6del7insA affects the exon 3B donor splice site and disrupts the PLP1-transcript without affecting the DM20, was found in a patient with severe Pelizaeus-Merzbacher disease and in his female cousin with early-onset spastic paraparesis. Mutation c.191+1G>A causes exon 2 skipping with a frame shift, is expected to result in a functionally null allele, and was found in a patient with mild Pelizaeus-Merzbacher disease and in his aunt with late-onset spastic paraparesis. Mutation c.696+1G>A utilizes a cryptic splice site in exon 5, causes partial exon 5 skipping and in-frame deletion, and was found in an isolated patient with a severe classical Pelizaeus-Merzbacher. PLP1 splice-site mutations express a variety of disease phenotypes mediated by different molecular pathogenic mechanisms.
© The Author(s) 2013.

Entities:  

Keywords:  PLP1; Pelizaeus-Merzbacher disease; splice-site mutations

Mesh:

Substances:

Year:  2013        PMID: 23771846     DOI: 10.1177/0883073813492387

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

1.  PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1/DM20 alternative splicing.

Authors:  Jennifer R Taube; Karen Sperle; Linda Banser; Pavel Seeman; Barbra Charina V Cavan; James Y Garbern; Grace M Hobson
Journal:  Hum Mol Genet       Date:  2014-06-01       Impact factor: 6.150

Review 2.  Neurogenetics of Pelizaeus-Merzbacher disease.

Authors:  M Joana Osório; Steven A Goldman
Journal:  Handb Clin Neurol       Date:  2018

3.  Elucidation of the pathogenic mechanism and potential treatment strategy for a female patient with spastic paraplegia derived from a single-nucleotide deletion in PLP1.

Authors:  Keiko Yamamoto-Shimojima; Taichi Imaizumi; Yusuke Aoki; Ken Inoue; Tadashi Kaname; Yusuke Okuno; Hideki Muramatsu; Kohji Kato; Toshiyuki Yamamoto
Journal:  J Hum Genet       Date:  2019-04-19       Impact factor: 3.172

Review 4.  Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.

Authors:  Kavitha Siva; Giuseppina Covello; Michela A Denti
Journal:  Nucleic Acid Ther       Date:  2014-02       Impact factor: 5.486

5.  Altered PLP1 splicing causes hypomyelination of early myelinating structures.

Authors:  Sietske H Kevelam; Jennifer R Taube; Rosalina M L van Spaendonk; Enrico Bertini; Karen Sperle; Mark Tarnopolsky; Davide Tonduti; Enza Maria Valente; Lorena Travaglini; Erik A Sistermans; Geneviève Bernard; Coriene E Catsman-Berrevoets; Clara D M van Karnebeek; John R Østergaard; Richard L Friederich; Mahmoud Fawzi Elsaid; Jolanda H Schieving; Maja Tarailo-Graovac; Simona Orcesi; Marjan E Steenweg; Carola G M van Berkel; Quinten Waisfisz; Truus E M Abbink; Marjo S van der Knaap; Grace M Hobson; Nicole I Wolf
Journal:  Ann Clin Transl Neurol       Date:  2015-05-01       Impact factor: 4.511

Review 6.  Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.

Authors:  Natasha Caminsky; Eliseos J Mucaki; Peter K Rogan
Journal:  F1000Res       Date:  2014-11-18

7.  Unusual presentation of pelizaeus-merzbacher disease: female patient with deletion of the proteolipid protein 1 gene.

Authors:  Teva Brender; Donna Wallerstein; John Sum; Robert Wallerstein
Journal:  Case Rep Genet       Date:  2015-02-18

Review 8.  Cellular Pathology of Pelizaeus-Merzbacher Disease Involving Chaperones Associated with Endoplasmic Reticulum Stress.

Authors:  Ken Inoue
Journal:  Front Mol Biosci       Date:  2017-02-24

9.  Morpholino Antisense Oligomers as a Potential Therapeutic Option for the Correction of Alternative Splicing in PMD, SPG2, and HEMS.

Authors:  Stephanie Tantzer; Karen Sperle; Kaitlin Kenaley; Jennifer Taube; Grace M Hobson
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-05       Impact factor: 8.886

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.